SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-20-001660
Filing Date
2020-02-14
Accepted
2020-02-14 11:54:58
Documents
1
Group Members
ALTIUM CAPITAL GROWTH GP, LLCALTIUM GROWTH FUND, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G ormp-sc13ga_123119.htm SC 13G/A 128309
  Complete submission text file 0001387131-20-001660.txt   130080
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Subject) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: SC 13G/A | Act: 34 | File No.: 005-79895 | Film No.: 20616243
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176
Business Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A